Your browser doesn't support javascript.
loading
Treatment Efficacy of PD-1 Inhibitor Therapy in Patients With Recurrent and/or Metastatic Salivary Gland Carcinoma.
Hashimoto, Kazuki; Yasumatsu, Ryuji; Kuga, Ryosuke; Hongo, Takahiro; Yamamoto, Hidetaka; Matsuo, Mioko; Wakasaki, Takahiro; Jiromaru, Rina; Manako, Tomomi; Toh, Satoshi; Masuda, Muneyuki; Yamauchi, Moriyasu; Kuratomi, Yuichiro; Uryu, Hideoki; Nakashima, Torahiko; Tamae, Akihiro; Tanaka, Risa; Taura, Masahiko; Takeuchi, Toranoshin; Yoshida, Takamasa; Nakagawa, Takashi.
Afiliación
  • Hashimoto K; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Yasumatsu R; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; yasumatsu.ryuji.847@m.kyushu-u.ac.jp.
  • Kuga R; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Hongo T; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Yamamoto H; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Matsuo M; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Wakasaki T; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Jiromaru R; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Manako T; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Toh S; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Masuda M; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Yamauchi M; Department of Head and Neck Surgery, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Kuratomi Y; Department of Head and Neck Surgery, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Uryu H; Department of Otolaryngology Head and Neck Surgery, Saga University Faculty of Medicine, Saga, Japan.
  • Nakashima T; Department of Otolaryngology Head and Neck Surgery, Saga University Faculty of Medicine, Saga, Japan.
  • Tamae A; Department of Otorhinolaryngology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Tanaka R; Department of Otorhinolaryngology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Taura M; Department of Otorhinolaryngology, Hamanomachi Hospital, Fukuoka, Japan.
  • Takeuchi T; Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan.
  • Yoshida T; Department of Otorhinolaryngology, Fukuoka University Hospital, Fukuoka, Japan.
  • Nakagawa T; Department of Otorhinolaryngology, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
Anticancer Res ; 42(2): 981-989, 2022 Feb.
Article en En | MEDLINE | ID: mdl-35093898
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_mouth_oropharynx_cancers Asunto principal: Neoplasias de las Glándulas Salivales / Carcinoma / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Anticancer Res Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_mouth_oropharynx_cancers Asunto principal: Neoplasias de las Glándulas Salivales / Carcinoma / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Anticancer Res Año: 2022 Tipo del documento: Article País de afiliación: Japón